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Abstract 
Individuals with body dysmorphic disorder (BDD) often experience negative distorted 
images of their appearance, and research suggests these may be linked to memories of 
adverse events such as bullying or teasing. This study evaluates imagery re-scripting (ImR) as 
an intervention for BDD. In this article we present a multiple-baseline single case 
experimental design testing imagery re-scripting as a brief, standalone intervention, with six 
individuals with BDD that related to aversive memories. The impact of the intervention was 
assessed by self-reported daily measures of symptom severity (preoccupation with 
appearance; appearance-related checking behaviors; appearance related distress; strength of 
belief that their main problem is their appearance) and standardized clinician ratings of BDD 
severity (Yale-Brown Obsessive Compulsive Scale modified for BDD). Four out of six of the 
participants responded positively to the intervention, with clinically meaningful improvement 
in their symptomatology. Overall response was rapid; improvements began within the first 
week post ImR intervention. From a small sample it is cautiously concluded that imagery re-
scripting may show promise as a module in cognitive behavior therapy for BDD, and is 
worthy of further investigation.  
 
Key Words: body dysmorphic disorder; cognitive behavior therapy; imagery rescripting; 
single case experimental design. 
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Imagery Rescripting for Body Dysmorphic Disorder: a multiple-baseline single case 
experimental design  
 Individuals with body dysmorphic disorder (BDD) are preoccupied with a perceived 
defect or flaw in their physical appearance that is not observable to others or appears only 
slight. To fulfill the diagnostic criteria, they must also experience clinically significant 
distress or impairment in social, occupational, or other important areas of functioning 
(American Psychiatric Association, 2013). The prevalence of BDD is reported to be up to 
2.4% in the US population (Koran, Abujaoude, Large, & Serpe, 2008). BDD is a chronic 
condition, which usually develops during adolescence (Veale, Boocock, et al., 1996)  and has 
significant negative impact on quality of life (Phillips, 2000). Suicide rates in individuals 
with BDD are high, with as many as 80% reporting lifetime suicidal ideation and up to 28% 
attempting suicide (Phillips et al., 2006 ; Veale, Boocock, et al., 1996) .   
 Cognitive Behavior Therapy (CBT) for BDD has traditionally focused upon cognitive 
restructuring and exposure and response prevention or behavioral experiments (Veale & 
Neziroglu, 2010; Wilhelm, Phillips, & Steketee, 2013). There are only four randomized 
controlled trials testing CBT versus a waiting list as a treatment for people with BDD (Rabiei, 
Mulkens, Kalantari, Molavi, & Bahrami, 2012; Rosen, Reiter, & Orosan, 1995; Veale, 
Gournay, et al., 1996; Wilhelm et al., 2014). All studies reported a significant reduction in 
symptoms associated with BDD compared to the waiting list. Lastly, Veale et al. (2014)  have 
shown CBT to be superior to anxiety management for BDD. In clinical practice individuals 
with BDD are frequently regarded as difficult to treat, and a significant number fail to 
respond or to make a full recovery. 
 A distorted body image and excessive self-focused attention are central features of a 
model of ‘the self as an aesthetic object’, which is characteristic of people with BDD (Veale, 
2004; Veale, Boocock, et al., 1996). Evidence for the experience of distorted imagery in 
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BDD comes from a descriptive study that compared 18 participants with BDD with 18 
healthy controls using a semi-structured interview and questionnaires (Osman, Cooper, 
Hackmann, & Veale, 2004). The BDD and control groups were equally likely to experience 
spontaneous images of their appearance. However, people with BDD were found to have 
appearance-related images that were significantly more negative, more recurrent, and viewed 
more from an observer perspective (seeing themselves in their minds eye from another 
person’s viewpoint) than were those of the control participants. These images were more 
vivid, detailed, and distorted, and typically involved bodily sensations. The content of the 
images was frequently related to early aversive memories from childhood or adolescence. 
The most common memories were of bullying or teasing.  
These findings were confirmed by Buhlmann, Cook, Fama, and Wilhelm (2007) and 
Buhlmann et al. (2011)  who also found that people with BDD reported memories of more 
appearance and competency-related teasing than did mentally healthy control participants. 
Kosslyn, Ganis, and Thompson (2001) note that while mental images often take a visual 
form, they may include other sensory modalities as well, such as the auditory, olfactory, or 
kinesthetic. People with BDD are frequently comparing or scrutinizing their area of concern 
within their mind’s eye, and imagining how their feature appears to others (Veale, 2004). 
 The prevalence of imagery linked to aversive experiences in BDD could indicate that 
imagery based techniques might be worthy of investigation. Imagery Rescripting (ImR) has 
received increasing interest as an intervention for people who experience distressing images 
(Holmes, Arntz, & Smucker, 2007). ImR was originally developed for posttraumatic stress 
disorder (PTSD) (Smucker & Dancu, 1999) and personality disorder (Arntz & Weertman, 
1999) and involves techniques that transform distressing mental images into more benign 
entities or construct new positive images. Holmes et al. (2007) demonstrated that imagery has 
greater power to affect emotion than verbal processing, and that emotional memories are far 
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more likely to be represented as images than as verbal thoughts. ImR is not typically used as 
a standalone intervention in 4 RCTs for CBT for BDD (Rabiei et al., 2012; Rosen et al., 
1995; Veale, Gournay, et al., 1996; Wilhelm et al., 2014) but has been used as a optional  
module in a treatment protocol for one RCT (Veale et al., 2014). Thus it would be helpful to 
determine if a module using ImR has any efficacy in for people with BDD who report images 
and so would strengthen the rationale for its inclusion in CBT packages. The evidence to date 
for ImR in other disorders has been dominated by case studies and pilot RCTs with small 
sample sizes. For example, Nilsson, Lundh, and Viborg (2012) conducted a small RCT 
(n=14) comparing ImR with a reading task in participants with social phobia. They found a 
significant reduction in symptoms of social phobia across a number of measures. ImR has 
demonstrated some efficacy mainly in people suffering from a range of conditions such as 
social phobia (Nilsson et al., 2012; Wild & Clark, 2011; Wild, Hackmann, & Clark, 2008), 
PTSD (Hackmann, 2011), depression (Wheatley & Hackmann, 2011), personality disorder 
(Arntz & Weertman, 1999), simple phobia (Hunt & Fenton, 2007) and obsessive compulsive 
disorder (OCD) (Veale, Page, Woodward, & Salkovskis, 2015).  
In a recent review of the ImR literature, Arntz (2012) concluded that the results are 
encouraging in terms of efficacy of the technique, but that the RCTs or case series that have 
been carried out have been underpowered or with inadequate control conditions. There may 
be a number of possible mechanisms that account for the effects of ImR. They typically focus 
upon imagining that an aversive memory is changed so that the outcome is more desirable, or 
at least less aversive (Arntz, 2012), for example through emotional processing, a change in 
memory representation, counter conditioning (such as adding a soothing image), a change in 
the meaning of the imagery, and a change in the sense of ‘nowness’ or context of the 
imagery. However, these putative mechanisms have not been fully investigated.  
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 Because people with BDD have a distorted body image and share a number of 
features with OCD and social phobia (Coles et al., 2006; Wilhelm & Neziroglu, 2002), 
interventions that have been of benefit for OCD and social phobia are of particular interest to 
those trying to help people with BDD. ImR has not previously been evaluated for BDD but it 
seems to be a logical choice given the central nature of imagery in BDD and the frequent 
emotional links to aversive early memories. It also offers the opportunity to develop an 
alternative understanding and context for their body image, whilst avoiding verbal debate 
about whether the person has a perceived or “real” defect on whether it means they will be 
rejected, which is considered ineffective in BDD (Neziroglu & Khemlani-Patel, 2002). 
 The aim was therefore to conduct a proof of concept study investigating ImR in BDD 
using a multiple-baseline single case experimental design (SCED). This method of 
investigation places emphasis on observing change in the individual. It is the frequency of the 
measurement, which enables both the presence and degree of change and the pattern of 
change to be observed. The multiple baseline design replication, another key characteristic of 
SCED, and the staggered baselines allow greater control over potential maturation and 
history effects and the impact of extraneous co-existing events to enable ImR-related 
improvements to be identified (Hayes, 1981). The advantage of a stand-alone intervention is 
that it helps to ‘unbundle’ complex interventions like CBT and determine whether a given 
intervention is worthy of inclusion as a treatment module. We chose to build on the results of 
previous studies that have investigated ImR in the treatment of a range of disorders. We 
enhanced the experimental strength of the study by using a randomization to baseline length, 
by adding a control intervention, by ensuring long term follow up, and by avoiding any other 
intervention after the ImR. Our hypotheses were that the ImR intervention phase would result 
in significant improvements in the participants’ preoccupation with their appearance and 
degree of distress. Our secondary aims were to examine whether the ImR intervention phase 
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decreases the frequency of checking; enhances participants’ engagement in a psychological 
understanding of their condition and is associated with clinically significant improvement in 
symptoms of BDD and depression at the 6 month follow-up. 
     Method 
Design 
The present study employed an adapted multiple baseline ABC SCED with 
randomization to intervention point, (i.e. where A is baseline before intervention, B is the 
single session control intervention followed by two weeks of symptom monitoring, and C is 
the single session ImR intervention followed by further symptom monitoring phase). The first 
author, using a random number generator to allocate participants to different baseline lengths, 
conducted randomization. The baseline lengths were 7, 14, 21 and 28 days. 
Participants 
We invited six consecutive participants who experienced imagery with memories that 
appeared linked to their concerns about their appearance to take part in the study following 
routine assessment in private practice. No other participants were recruited. No charge and no 
compensation was made for participation. All were offered six further sessions following 
completion of the follow up period. All participants completed the study. None had 
previously been given ImR. In addition, they fulfilled the following inclusion criteria: (a) 
diagnosis of BDD with the Structured Clinical Interview for DSM-IV Disorders (SCID) 
(First, Spitzer, Gibbon, & Williams, 1995), (b) no change to any current pharmacological 
treatment and no plans to start pharmacological treatment in the 4 weeks prior to entering the 
study, (c) a total score of 20 or more on the Yale Brown Obsessive Compulsive Scale 
modified for BDD (BDD-YBOCS) (Phillips et al., 1997), (d) aged 18 years or over. The 
following exclusion criteria were used: (a) co-morbidity of psychosis or borderline 
personality disorder (a diagnosis of delusional disorder relating to appearance was not 
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grounds for exclusion), (b) current alcohol or substance dependence, (c) concurrent additional 
psychotherapy.  
Clinical Details 
Participant A was a 23-year old female student, who had had BDD for 8 years. She 
had co-morbid diagnosis of depression. She reported two previous trials of CBT for BDD, the 
last occurring 17 months previously, with little if any reported improvement in her 
symptoms. Her main areas of concern were her skin being ‘marked’ and scarred, eyes the 
wrong shape, and hair too thin, with which she was preoccupied for at least eight hours of the 
day. Participant A was not taking any medication. 
Participant B was a 21-year-old male with BDD of approximately seven years 
duration. His problem was triggered when he developed mild acne, and became afraid that he 
would lose his reputation for being good looking and ‘cute’.  He would spend at least three 
hours a day researching dermatological treatments to ensure that his skin did not ‘flare up’, 
but his main coping strategy had become avoidance of social situations.  He did not feel that 
he would avoid social situations if his appearance was improved. Participant B was not taking 
any psychiatric medication and had not had previous CBT. 
Participant C was a 27-year-old male preoccupied with a fear of losing his hair. He 
had co-morbid depression.  He reported two previous trials of CBT; one of six sessions of 
exposure and response prevention, and one of eight sessions of mindfulness based CBT, and 
reported that they had yielded limited benefit. He spent many hours researching nutrition, 
hormones, and shampoo products related to hair loss on the Internet.  He would have 
‘debates’ almost every day with his parents about how much hair he was losing and what the 
best strategy for prevention of further hair loss might be. Participant C had been taking high-
dose SSRI type anti-depressants for the past three years and was taking 60mg fluoxetine 
daily. 
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Participant D was a 19-year-old female student, whose main concerns were the size of 
her breasts, the shape of her thighs, and the skin on her face. She would spend around four 
hours each day researching cosmetic and dermatological treatments. She had attended 18 
sessions of CBT, completed eight months previously, which had focused upon social anxiety 
and low self-esteem, and had achieved a modest improvement according to the participant. 
Participant D was not taking any medication, although she had had a brief trial of citalopram 
20mg a year earlier. 
Participant E was a 29 year old female shop assistant suffering from preoccupation 
with bags under her eyes, which she felt that she had caused through smoking cigarettes and 
staying up late as a teenager. She completely avoided all mirrors and reflective surfaces, and 
would become extremely distressed if she did accidentally see her face in a reflective surface. 
Consequently her range of activities was greatly narrowed, as it was restricted to areas where 
she knew the location of all reflective surfaces. She had not accepted medication and had 
undergone some integrative psychotherapy three year earlier, with no effect upon her BDD 
symptoms. 
Participant F was a 35 year old female, preoccupied with the size and shape of her 
nose, and the fact that it no longer ‘matched’ her eyes following a rhinoplasty. She would 
take great care to avoid reflective surfaces for most of the day, but would at times become 
‘stuck’ examining her face.  She would spend several hours a day ruminating upon her regret 
- ‘if only’ she had chosen not to have the surgery - and wishing that other people had 
dissuaded her from it. She had a comorbid diagnosis of depression, and was taking fluoxetine 
20mg.  She had had no previous trials of SSRI or CBT. 
The study received ethical approval from the NRES Committee London – Bentham. 
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Measures  
The primary outcome measure was the daily self-monitoring of the degree of BDD-
related preoccupation and the level of distress experienced. These two measures were 
selected for analysis and report in this paper as they are core defining criteria of BDD 
(American Psychiatric Association, 2000). The daily record sheet asked participants to 
monitor the degree of preoccupation experienced on that day, on a scale where 0 = not at all 
and 100 = totally preoccupied, on my mind all day. The level of distress was assessed in the 
same manner where 0 = not distressed at all and 100 = completely distressed. The daily 
frequency of appearance related checking behavior was also recorded.  
A single item included on the daily record sheet assessed the degree to which 
participants accepted a psychological model of their problem.  Participants were asked to 
mark on a Visual Analogue Scale (VAS) from 0, “My main problem is the way I look”, to 
100, “My main problem is one of worrying excessively about the way I look”. This was 
completed daily up until the end of the final baseline period. The intensity of other BDD 
symptoms (e.g., degree to which I rate my appearance as ugly) was also recorded but is not 
included in this report for reasons of space. Participants completed this daily self-monitoring 
until the end of the 6
 
month observation period.  
 
Standardized measures of symptom severity  
In this study, standardized measures of symptom severity were not the primary 
outcome measure as single case designs require frequent (usually daily) measures. However, 
they provided a context for the interpretation of any improvements recorded by the daily 
measures and were administered at the initial assessment, end of baseline phase, post control 
intervention, post ImR intervention, and at 3 and 6 month follow-ups.  
 The Yale-Brown Obsessive-Compulsive scale modified for BDD (BDD-YBOCS) 
(Phillips et al., 1997) was used to rate the severity of BDD during the previous week. It is an 
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observer rated tool containing 12 items assessing BDD symptoms. Each item is rated 0 (no 
symptoms) to 4 (extreme symptoms). The range is 0-48 where a higher score indicates 
greater severity. The accepted cut-off for presence of BDD is >20 (Phillips, Hart, & Menard, 
2014).   It has been widely used in randomized controlled trials to test efficacy of treatment 
and has high internal reliability (α= 0.92) (Phillips et al., 2014). 
 The Beck Depression Inventory (BDI) (Beck & Steer, 1984; Beck, Steer, & Garbin, 
1988) is a self-report measure designed to assess depressive symptomatology experienced 
over the previous two weeks. It consists of 21 groups of statements and asks the respondent 
to select the one that best describes how they have been feeling. Internal consistency of the 
BDI ranges from .86- .88 in psychiatric populations, with a clinical mean score ranging from 
19.28 (SD 10.87) to 23.16 (SD 9.55). Cut-off scores for the BDI are <10 = minimal; mild to 
moderate = 10-18; moderate to severe = 19-29; severe = 30-63.  
Interventions  
Participants were informed that the investigation was to determine whether talking or 
imagining bad experiences in the past had any benefit on the symptoms of BDD. In the first 
phase they were asked to describe the imagery and memories out loud, with the rationale to 
see what happens if the therapist and participant can understand the event better. In the 
second phase the rationale was to see what happens if they can imagine changing the events 
in a way that helps them to feel better in the image. The ImR intervention originates from 
Arntz and Weertman (1999) in which participants re-visit their memory of traumatic 
childhood images in three stages: 1) The participant re-lives the image as a child and the child 
describes their needs; 2) The participant enters the image as an adult, to provide the child’s 
needs and provide a different perspective; 3) The participant then returns to the image as a 
child, with the adult self in the room to determine if the child has any further needs. As 
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described by Wild and Clark (2011), Arntz and Weertman (1999)’s procedure was adapted 
for this study by incorporating cognitive restructuring of the meaning related to the image.  
ImR step 1 by identification of a recent trigger 
 The starting point for the ImR intervention is a recent moment in which the individual 
experienced distress about the perceived appearance defect. Either the bodily location of 
distress (‘felt-sense’) or the negative meaning can be used as a ‘bridge’ to the earliest 
memory of thinking or feeling that way and identifying the associated memory. 
ImR step 2 by contextualization and cognitive restructuring 
 During step 2, the therapist and client work together to challenge the meaning of the 
early event and its implications for the present. For example, if a client’s memory is of being 
bullied and interpreted the event as meaning “I’m ugly and disgusting; people will reject me 
or laugh at me if I reveal my flaws,” he/she would be encouraged for the younger self to 
identify their needs and for the wise adult to come up with alternative ways of viewing the 
event with a compassionate perspective.  In essence, the therapist helps the client to 
distinguish between what happened when he/she was a young child/teenager and what 
happens now as an adult in order to help him/her to see the event as an exceptional, time-
limited experience, without implications for the present or future. The participant would then 
incorporate what the younger self needs and the new meaning into the next rescripting phase. 
ImR step 3 by rescripting 
 During the rescripting step, participants are asked to imagine entering the scenario 
identified in step one to ‘rescript’ and change events in the memory so as to provide the 
younger self with what they need in order to feel better. They are encouraged to convey to the 
younger self the alternative perspective they have come up with in the cognitive restructuring 
phase, and if they are able, to offer some physical comfort such as a hug. Finally, they relive 
the event from the perspective of their younger self with their adult self in the room with 
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them. This time the younger self is also asked if there is anything else that the younger self 
needs in order to feel safer or has doubts about, and Step 2 may be repeated to incorporate 
this material. 
Procedure 
The diagnosis of BDD was made independently prior to referral to the study. 
Following a baseline phase A (7, 14, 21 or 28 days) participants received a control 
intervention (B) in which they were asked to simply describe the imagery and memories out 
loud, but with no other intervention in a single standalone therapeutic session of 50 minutes’ 
duration. After a period of symptom monitoring (14 days) they received ImR in another 
single standalone therapeutic session of 90 minutes (C) followed by a further symptom 
monitoring phase of 7 days. Follow-up sessions were conducted after 3 and 6 months. 
Participants received no additional therapy before completion of the 6-month follow-up. The 
first author conducted the clinical assessments.  
Data Analysis 
The data were first graphed according to standard presentation in SCED and then 
assessed in terms of an experimental criterion (Did the ImR have an effect?) and a therapeutic 
criterion (Was the effect clinically significant?) (Kazdin, 1998). This was achieved by using 
visual analysis (VA) of the graphs. Whilst VA is considered to be a relatively insensitive 
approach, especially when there is a great deal of day-to-day variability, it is this 
characteristic which makes it useful for identifying potent interventions, more likely to give 
clinically relevant results (Kazdin, 1998).  The data were plotted using Excel and subjected to 
VA according to guidelines proposed by (Kazdin, 1998). This involves assessing certain 
characteristics of the graphs within and between each phase: (i) Change in the trend or level 
of the symptom severity across phases; (ii) The degree of the slope of the graph reflecting the 
strength of the trend change; (iii) Change in the variability of the data indicating stability of 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPTIMAGERY RESCRIPTING FOR BDD 
   
  
14 
symptom change. For statistical analysis we used ‘Tau-U’ (Parker, Vannest, Davis, & Sauber, 
2011) a test designed specifically for single case research. Tau-U is a combination of Mann-
Whitney U (between groups) and Kendall Tau (correlation) and can test for data non-overlap 
between phases. It is a distribution assumption-free test and considers all the data points, not 
only summary statistics (i.e., mean or median). It reflects the proportion of data that is 
different (or non-overlapping) from the comparison phase. The Tau-U statistic can be 
understood as the % of data that “improves” over time across the phases (baseline vs control; 
control vs ImR), and also takes into consideration any baseline trend (i.e., the direction a 
person’s symptoms were taking prior to intervention).  In addition to individual Tau statistics, 
a combined effect size across all the cases for each outcome variable was calculated. This is 
the ‘weighted average’ in which ‘weight’ is the inverse of the variance of the test statistic 
(http://www.singlecaseresearch.org/calculators/tau-u). The weighted average reflects the 
proportion of data that is non-overlapping between phases across all cases (for further details 
on Tau-U see Parker et al. (2011). 
Standardized measures  
The BDD-YBOCS scale was used to identify the number of participants who 
displayed (a) reliable change and  (b) clinically significant change (Jacobson & Truax, 1991) 
from baseline to 6 month follow up after an intervention. To achieve reliable change, the 
magnitude of change needs to be greater than the standard error of measurement of the 
difference (Reliable Change Index). We used the test retest reliability of 0.93 (Phillips et al., 
2014). We used “Criterion a” to determine clinically significant change on the BDD-YBOCS. 
This is pre to post-change of at least 2 standard deviations from the original mean pre-
intervention to post intervention. Criteria “b” and “c” were not used as no normative data 
were available for the non-clinical population. We used an Excel spread sheet, the Leeds 
Reliable Change Indicator (Morely & Dowzer, 2014). To determine criterion a, the clinical 
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norm data [mean = 35.42; SD = 6.61] was taken from a recent RCT for BDD (Veale et al., 
2014). In addition, we recorded the participants who achieved a 30% or greater decrease in 
the total BDD-YBOCS, which best corresponded to “much improved” on the Clinical Global 
Impression (CGI) scale (Guy, 1976). We used “Criterion c” to determine significant change 
for the Beck Depression Inventory in which we used a clinical mean of 23.16 (SD = 9.55) 
from a clinical sample (Beck & Steer, 1984) and 7.28 (SD = 6.28) in a normative sample with 
a test-retest reliability of 0.90 (Lightfoot & Oliver, 1985).  
Results 
Daily self-monitoring for preoccupation with appearance and distress are displayed in 
Figures 1 and 2. All six participants showed very little variability at baseline, suggesting that 
levels of preoccupation were relatively stable. Post-control intervention there was little 
change in the degree of preoccupation with appearance for cases A, B, E, and F. Cases C and 
D show an increase in preoccupation immediately followed by reduction. Following ImR 
participants A, D, E, and F showed significant reduction in preoccupation relative to post 
control phases.  For these participants there is a clear downward trend and/or a reduction in 
level, with pronounced change in slope indicating a swift and strong change in trend; the 
resulting change in level is maintained up to three months post ImR.  It is of note that 
participant F shows a more stepped reduction after ImR and the strongest level of inference 
that the treatment had an effect can be drawn from visual analysis of this participant’s results. 
Participants B and C showed little reduction in preoccupation post ImR. As shown in Tables 
1 and 2, there was no significant difference between baseline and the post control symptom 
monitoring phase for all participants except participant C.  Participants A, D, E and F showed 
a statistically significant change in level of non-overlapping data between the post control 
and the post ImR phases at p<0.01.  
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Table 1. 
Summary of Tau analysis comparing baseline phase (A) with post control intervention phase 
(B) across daily measures of preoccupation with appearance 
 
Case Tau SD Tau p value 90% CI 
A 0.000 0.222 1.000 
[-0.365, 0.365] 
B 0.071 0.222 0.748 [-0.294, 0.437] 
C -0.500 0.222 0.024* [-0.865, -0.135] 
D 0.000 0.274 1.000 [-0.450, 0.450] 
E 0.000 0.191 1.000 [-0.315, 0.315] 
F 0.000 0.191 1.000 [-0.315, 0.315] 
Weighted average -0.070  0.441 
95% CI 
[-0.248, 0.108]  
*p<0.05 **p<0.01  
Table 2.  
Summary of Tau analysis comparing post control phase (B) with post ImR intervention phase (C) 
across daily measures of preoccupation with appearance 
 
Case Tau SD Tau p value  90% CI 
A -0.991 0.164 0.000** 
[-1.261, -0.721] 
B -0.179 0.164 0.276* [-0.449, 0.091] 
C -0.371 0.170 0.029  [-0.651, -0.092] 
D -1.000 0.171 0.000**  [-1.282, -0.718] 
E -0.989 0.166 0.000**  [-1.263, -0.715] 
F -1.000 0.170 0.000**  [-1.280, -0.720] 
Weighted average -0.754  0.000** 
95% CI 
[-0.888, -0.619]  
*p<0.05 **p<0.01  
Visual inspection of the graph (Figure 2) indicated that participants A-E showed very 
little variability at baseline, suggesting that levels of distress were relatively stable prior to 
intervention. Participant F showed fluctuation during baseline, which was controlled for in 
the Tau analysis. Participants B and E showed little change in trend during the post control 
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symptom monitoring phase. Participants D, C and F reported fluctuation in distress during the 
post control symptom monitoring phase, with participants F and A showing a clear reduction 
in distress.  Following ImR participants A, D, and E showed significant decrease: however, 
participant F showed greater fluctuation.  Participant F had a reversal in slope suggesting that 
relative to trend, her level of distress was worsening, possibly due to an increased level of 
uncertainty as beliefs were challenged. For participants A and D, the slope was pronounced, 
indicating a strong and immediate response to the intervention. Participant B showed no 
change across all phases. As shown in Tables 3 and 4, Tau analysis showed participants A 
and F showed a significant reduction in distress between baseline and post control phase. All 
participants excluding participant B reported a statistically significant reduction in distress 
post ImR compared to period post control intervention.  
Table 3.  
Summary of Tau analysis comparing baseline phase (A) with post control intervention phase (B) 
across daily measures of distress 
 
Case Tau SD Tau p value  90% CI 
A -0.929 0.222 0.000**  [-1.294, -0.563] 
B 0.000 0.222 1.000  [-0.320, 0.320] 
C 0.429 0.222 0.054  [0.063, 0.794] 
D 0.143 0.274 0.602  [-0.307, 0.593] 
E 0.000 0.191 1.000 [-0.315, 0.315] 
F -0.806 0.191 0.000**  [-1.121, -0.492] 
Weighted average -0.215  0.018* 
95%CI 
[-0.393, -0.038] 
*p<0.05 **p<0.01  
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Table 4.  
Summary of Tau analysis comparing post control phase (B) with post ImR intervention phase (C) 
across daily measures of distress 
 
Case Tau SD Tau p value 90% CI 
A -0.964 0.164 0.000** [-1.235, -0.694] 
B 0.000 0.164 1.000 [-0.236, 0.236] 
C -0.359 0.170 0.035* [-0.639, -0.079] 
D -0.986 0.172 0.000** [-1.269, -0.704] 
E -0.978 0.166 0.000** [-1.252, -0.705] 
F -0.843 0.170 0.000** [-1.122, -0.564] 
Weighted average -0.687  0.000 
95%CI 
[-0.998, -0.718]** 
*p<0.05 **p<0.01  
Appearance-related Checking Behaviors  
All six participants showed some fluctuation in checking behaviors during the 
baseline period, but the level remained similar between baseline and the post control 
symptom monitoring phase (see Supplementary Figure 3).  Post ImR, participants D, E and F 
showed a pronounced change in slope, indicating a significant reduction in checking 
behavior.  However, the change in level for participant E was notably delayed. Checking does 
fluctuate from day to day but the trend showed consistent decline in checking behavior. 
Participant A showed a gradual reduction in checking behavior. Participants B and C showed 
little change in checking behavior across the phases. As displayed in Supplementary Tables 1 
and 2, participants A, D, E, and F showed significant change in checking behavior post ImR 
phase (p<0.001) with no difference between baseline and the post control phase. 
Engagement in a psychological understanding of their condition  
All participants showed very little spontaneous change in engagement in a 
psychological understanding of their appearance concerns during the baseline phase (see 
Supplementary Figure 4). Following the control intervention, participants A, B, C, E showed 
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a reduction, with modest slope, in the belief that their main problem was their actual physical 
appearance (as opposed to a psychological explanation such as that the problem was 
preoccupation with their appearance). Conversely, participant F showed an increase in the 
strength of her ‘problem is appearance’ belief, with a stepped change.  Following ImR, 
participants A, D, E, and F showed a significantly steeper reduction in the idea that their main 
problem was their appearance, relative to the post control phase. Participants B and C showed 
no significant reduction. Again, it is of note that participant F showed a more stepped 
reduction after ImR.  
As shown in Supplementary Tables 3 and 4, Tau analysis showed that all participants 
apart from participant D showed a statistically significant reduction in their strength of belief 
in a non-psychological explanation (p<0.01).  Following the ImR intervention, participants 
A, D, E, and F showed further reduction in this non-psychological understanding of their 
condition (p<0.01).  
Reliable and Clinically Significant Change on the BDD-YBOCS 
After the control intervention, no participant made reliable improvement on BDD-
YBOCS (Reliable Change Index of 5 points) nor met criterion a, for clinically significant 
change (score of below 22 on BDD-YBOCS).  After ImRs, four participants (A, D, E, F) 
showed reliable improvement in their symptoms and two remained unchanged. This 
translated into clinically significant change for these four participants, with A and D also 
achieving at least a 50% reduction in scores. At six month follow-up, participants A, D, E and 
F continued to improve and met both the  >30% and > 50% reduction in symptoms 
benchmark, with an overall reduction in scores ranging from 57 to 81%.  Participants B and C 
showed minimal improvement (see Table 5). 
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Table 5.  
BDD-YBOCS score from assessment to 6 month follow-up 
 
Participant Assessment End of 
baseline 
Post-
control 
Post-ImR 
therapy 
3 month 
follow up 
6 month follow up (% 
improvement from 
assessment) 
A 32 32 34 16 12 6 (81)
 RI, CS
 
B 22 22 22 22 24 22 (0) 
C 34 34 36 32 32 32 (6) 
D 20 20 20 10 8 8 (60) 
RI, CS 
E 28 26 28 18 18 12 (57) 
RI, CS
 
F 36 34 32 20 16 10 (72) 
RI, CS
 
RC 
Reliable Improvement 
CS
 Clinically Significant change 
Beck Depression Inventory  
Three participants showed reliable improvement (> 9 points) in their score from 
baseline to six month follow up (participants A, E and F) (Table 6). Two participants 
achieved Clinically Significant Change ( < 14 points) (participants A and F).   
Table 6.  
BDI score and percentage change from assessment to 6-month follow-up  
 
Participant Assessment End of 
Baseline 
Post-
control 
Post-ImR 
therapy 
3 month 
follow up 
6 month follow up (% 
improvement from 
assessment) 
A
1
 40 40 32 22 22 14
 
(65)
RI, CS
 
B 21 21 21 21 21 21 (0) 
C 37 36 36 37 36 36 (3) 
D
1
 15 15 15 10 10 10 (33) 
E
1
 36 34 31 24 24 13 (64)
RI
 
F
1
 36 34 32 21 21 15 (67)
RI, CS
 
RI 
Reliable Improvement, 
CS
 = Clinically Significant Change    
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     Discussion 
This study set out to test the efficacy of a single session of ImR to improve BDD 
symptoms; it was compared to a single session of simply to talking about an aversive 
memory. A single case experimental design was used which allowed the process of change to 
be examined as well as the impact of the intervention on BDD symptoms. The study found 
ImR improved preoccupation and distress in four out of the six participants. Of note is that 
this change started to occur within the first week post the intervention and continued up to 6 
months follow-up. Interestingly, these participants also showed a shift in their model of BDD 
from that of a physical defect to a psychological problem, shortly after ImR. Participants 
without improvement in symptoms maintained their “physical” explanation.  Changes in 
BDD preoccupation and distress measured by daily monitoring were also reflected in the 
standardized measures of BDD severity and depression. This indicates that a single 
standalone session of ImR resulted in clinically meaningful improvement for the majority of 
participants and was sustained at follow-up. 
 Our findings are consistent with the findings of other trials of ImR across a variety of 
conditions including social phobia (Wild et al., 2008) and PTSD (Hackmann, 2011). In 
common with Wild et al. (2008) and Nilsson et al. (2012), an interesting feature of the 
intervention was the speed with which change occurred. Improvement in preoccupation and 
distress occurred within five days of ImR for participants for whom the intervention was 
beneficial. This highlights the potency of imagery focused interventions and supports the 
assertion made by Holmes and Mathews (2010) that imagery may amplify emotional 
experience. Hence, it can then be speculated that the positive impact of the altered image is 
also magnified. To put the results into clinical context, individuals with BDD can require 
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multiple therapeutic sessions over a number of weeks before change occurs. Equally, trials to 
date that show CBT to be an effective treatment for BDD have used at least 12-16 sessions. 
The gains are greater than reported on the BDD-YBOCS in a RCT (Veale et al., 2014; 
Wilhelm et al., 2014). However, we would be extremely cautious about these results, as this 
report is of a small number of relatively selected cases. Furthermore, the aim was to 
investigate its utility as a module in CBT for BDD and determine if ImRs was different to 
just talking about an aversive memory linked to their image.  
In all participants the control intervention of describing a memory that they felt 
related to their concerns about their appearance had relatively little effect.  Our hypothesis is 
that since participants were being asked to describe the relevant event without using the first 
person present tense and without imagery, no emotional processing or re-framing is likely to 
have occurred. It might be that ImR can help engage people in a psychological model of 
BDD by focusing on concrete experiences that have contributed to the development of 
emotional problems other than current appearance concerns, for example, that the shame 
sufferers feel about their appearance is a product of humiliation felt when teased as a younger 
person, rather than a result of how they look. Other elements of traditional behavioral and 
cognitive therapy (such as behavioral experiments and alternative data logs) can be framed as 
helping to ‘update the system’, helping the mind to see the bad experiences as exceptions 
rather than the norm.   
Our results show that the strength of the belief in the psychological model increased 
in those participants who improved after ImR.  For participants A, D and F this shift in 
understanding occurred before the improvement in symptoms. However, our clinical 
impression was that ImR also enhanced engagement in psychological understanding prior to 
the change in participants A, D, E and F and that this was consistently reported by the four 
improved participants as the dimension of their problems that they felt changed most after the 
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ImR. The most obvious explanation is that a shift in their view of their appearance as an 
emotional problem was the most important aspect of reducing their preoccupation and 
distress. Further research is required into different approaches to assess this construct and the 
sequence of change of different variables.  
Although the data presented here supports the idea that ImR could be efficacious in 
BDD, two of the six participants did not respond to the intervention.  Clinical impression and 
feedback from the participants suggests that these participants found the intervention less 
credible, and that they were less able to engage in vivid imagery re-scripting. Imagery re-
scripting seems to have worked best in those examples when the participant reported the 
image as highly vivid. The relevance of vividness of visual imagery might be a fruitful area 
to explore when evaluating which participants might respond particularly well to ImR. In 
particular, this could involve the exploration of different degrees of vividness and different 
types of imagery related to sensory modality.  One standardized measure which could be used 
is the vividness of a visual imagery questionnaire (Marks, 1973). A further line of inquiry 
might investigate whether a certain level of openness to the notion that one has a 
psychological rather than an appearance problem has an effect on engagement. Identifying 
whether there is an association between perceived credibility and efficacy of imagery prior to 
ImR and the level of improvement would help in the understanding of whether this is a 
predictor of response.  
The failure of the intervention to provide any benefit for two participants initiates 
reflection as to whether the intervention could be modified. Firstly, to target lack of “buy-in” 
to the imagery-based intervention a pre-ImR phase could be developed to target doubts and 
reservations. This could take place some weeks prior to the start of the intervention or until 
patients reached a certain threshold of engagement in the use of imagery. Secondly, it is not 
yet known if cognitive restructuring is an essential component of ImR for BDD. Nilsson et al. 
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(2012) showed significant reduction in symptoms of Social Phobia without cognitive 
restructuring and focusing on providing what the child needed and changing the context of 
the memory.  These adaptations of the intervention could be tested using a more sophisticated 
SCED tracking mediational variables, potentially within session, which would allow data to 
be obtained, telling us precisely if and when these changes occur.  
This study provides evidence highlighting the potential of ImR as a potentially useful 
intervention for individuals with BDD. However, it would be premature to generalize the 
findings and recommend its use for all individuals. Instead this study should initiate further 
research to refine the intervention technique and identify individuals for whom it will be most 
effective. A series of larger SCEDs could systematically investigate: whether individuals 
without clearly identifiable images linked to aversive memories would benefit (individuals 
were recruited to this study if they had such memories); whether certain individuals who do 
not initially respond to the single intervention would improve with multiple sessions; whether 
those with “realistic” ImR have better outcomes; or whether those with ImR with an 
alternative explanation for the protagonists’ negative responses to appearance have a better 
outcome (e.g., participant D described her adult self offering reassurance that it was her 
mother’s anger problem that was to blame for the names that she was called).   
Limitations 
One limitation is that the first author solely conducted all aspects of treatment and the 
observer rated BDD-YBOCS and this may have introduced a bias in this measure. This 
would be a significant flaw if the BDD-YBOCS were the primary outcome measure. 
However, the study is consistent with the tradition in single case design that the daily self-
report measures are the primary outcome measures and that any evidence for efficacy is 
derived by the comparison between phases on the daily diary recordings of preoccupation and 
distress.  
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A further limitation of the study is that there were no integrity checks (i.e., 
independent evaluator of adherence of the therapist to ImR intervention). The therapist had 
however, been trained in the intervention and received regular supervision, which routinely 
uses audio recordings. Therefore, it is not possible to clearly demonstrate that the intervention 
was effective because it was ImR per se rather than non-specific strategies. A replication of 
this study should rectify this limitation by recording all sessions and randomly selecting a 
proportion for evaluation by an independent assessor and validating an adherence scale. 
Furthermore, a future study could assess the efficacy of the intervention by replicating across 
multiple therapists, to determine if specific therapist factors are important. 
The fact that three of the participants (A, C, D) had previously engaged in CBT, and 
A and D were amongst those who responded, could be seen as a confounding variable.  While 
it may have had some preparatory value and potentially helped make the psychological 
account plausible, we note first that previous therapy had taken place at least six months 
before assessment for this study, second that all participants met inclusion criteria and clinical 
levels on all standardized symptom measures, and third showed stable baselines and little or 
no response to the control intervention on the primary outcome measures (preoccupation and 
distress). We would suggest therefore that this does show ImR may have promise for 
individuals with stable and potentially refractory problems.  
Lastly we have considered whether the offer of evidence based CBT at no charge at 
the end of 6 months may bias the results. However, in this country, CBT is available at no 
charge in the state sector and so there is a disincentive for participating in research in this 
setting as they could have received CBT in the state sector much earlier. Furthermore, the 
credibility of CBT in BDD and the expectancy for change during treatment has been rated as 
extremely low in one trial (Veale et al., 2014) and so the promise of CBT after 6 months is 
unlikely to bias the results.   
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Conclusions 
In summary, this study shows that ImR may be a useful component for treating BDD in 
individuals with BDD who report aversive memories that are emotionally linked to their 
imagery. The choice of a SCED enabled exploration of how the ImR may achieve its effects 
and informed the direction of future development of the intervention. A focus on the 
processes underpinning ImR fits with the desire expressed by researchers to improve 
understanding of mechanisms of change in psychotherapy (Carey, 2011). We would also 
suggest that if ImR is used as a module, then to use it early in therapy to help engage a client 
in a psychological understanding of the problem and to maximize any gains early on in 
treatment.  
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Figure 1 Degree of preoccupation with appearance over time (days) for cases A-F 
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Figure 2 Level of distress ratings over time (days) for cases A-F 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPTIMAGERY RESCRIPTING FOR BDD 
   
  
36 
 
 
 
Hightlights: 
 
 Imagery re-scripting (ImR) shows promise as a key module in CBT for BDD 
 We examine response to ImR of 6 participants in detail  
 A series of single case-designs is employed 
 Idiosyncratic and standardised measures are employed. 
 Both visual and statistical analysis of results is utilised 
